Science Explorer Back to mapMap

Most cited papers from University Hospital Olomouc

What are the most cited papers from University Hospital Olomouc?

The most cited paper from University Hospital Olomouc is "Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma" (Robert John Motzer et al., 2018), with 4,756 citations. Next come "Recovery of large carnivores in Europe’s modern human-dominated landscapes" (1,906) and "Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma" (1,811).

Showing 50 of 60 papers. Every paper with more than 172 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access 21 Mar 2018 4,756
2 Recovery of large carnivores in Europe’s modern human-dominated landscapes Guillaume Chapron et al. · Science Open access 19 Dec 2014 1,906
3 Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access 13 Feb 2021 1,811
4 Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma A. Keith Stewart et al. · New England Journal of Medicine Open access 6 Dec 2014 1,342
5 Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin et al. · Journal of Clinical Oncology Open access 23 Oct 2023 1,055
6 Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial Brian I. Rini et al. · The Lancet 9 May 2019 1,029
7 Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study Meletios Athanasios Dimopoulos et al. · The Lancet Oncology Open access 5 Dec 2015 861
8 Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial Robert John Motzer et al. · The Lancet Oncology Open access 16 Aug 2019 797
9 Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma Toni K. Choueiri et al. · New England Journal of Medicine Open access 18 Aug 2021 792
10 Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial Gerhard Hindricks, Miloš Táborský, Michael Glikson et al. · The Lancet Aug 2014 746
11 Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development Wanyang Liu et al. · PLoS ONE Open access 20 Jul 2011 729
12 Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation Pavel P. Osmancik et al. · Journal of the American College of Cardiology Open access Jun 2020 651
13 Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Michel Attal et al. · The Lancet 130 authors 14 Nov 2019 648
14 Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study Gilles Salles, Johannes Duell, Eva M. González-Barca et al. · The Lancet Oncology Open access 5 Jun 2020 535
15 Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study Emmanuel Ekanem et al. · Nature Medicine Open access139 authors Jul 2024 484
16 Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology Martin Hoenigl et al. · The Lancet Infectious Diseases Open access 17 Feb 2021 466
17 Randomized phase III study 306 Gregory L. Krauss et al. · Neurology 125 authors 19 Apr 2012 433
18 Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke Pierre Amarenco et al. · New England Journal of Medicine Open access 16 May 2018 376
19 Osteolysis around total knee arthroplasty: A review of pathogenetic mechanisms Jiří Gallo, Stuart Barry Goodman, Yrjö Tapio Konttinen et al. · Acta Biomaterialia Open access 10 May 2013 359
20 Antibacterial Surface Treatment for Orthopaedic Implants Jiří Gallo, Martin Holinka, Calin Stefan Moucha · International Journal of Molecular Sciences Open access 11 Aug 2014 344
21 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial Michael J. Morris et al. · The Lancet Open access Sep 2024 333
22 Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022 Marco Pennazio et al. · Endoscopy Open access 24 Nov 2022 328
23 Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders F. M. Ross et al. · Haematologica Open access 27 Feb 2012 327
24 COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) Livio Pagano et al. · Journal of Hematology & Oncology Open access196 authors 14 Oct 2021 321
25 Practice-Based Research in the Creative Arts: Foundations and Futures from the Front Line Linda Candy, Ernest Edmonds · Leonardo Open access 20 Jun 2017 315
26 Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT) Jan Václavík, Richard Sedlák, Martin Plachý et al. · Hypertension 3 May 2011 307
27 Obstructive sleep apnea, depression and cognitive impairment Jakub Vaněk, Ján Pavlov Praško, Samuel Genzor et al. · Sleep Medicine 23 Mar 2020 305
28 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation Pavel P. Osmancik et al. · Journal of the American College of Cardiology Open access 5 Nov 2021 301
29 A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis Richard Langford, Jan Mareš, Alena Novotná et al. · Journal of Neurology 21 Nov 2012 299
30 A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction Richard A. Lafayette, Pietro A. Canetta, Brad H. Rovin et al. · Journal of the American Society of Nephrology Open access 7 Nov 2016 294
31 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer Alison Patricia Klein et al. · Nature Communications Open access123 authors 2 Feb 2018 285
32 Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis Amit Kishore, Martin Petřek · Frontiers in Immunology Open access 13 Aug 2021 284
33 Phenotypes of organ involvement in sarcoidosis Jonas C. Schupp et al. · European Respiratory Journal Open access 2018 256
34 Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study Bohuslav Melichar, Antoine Adenis, Albert Craig Lockhart et al. · The Lancet Oncology 26 Feb 2015 256
35 Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment Stuart Barry Goodman, Jiří Gallo · Journal of Clinical Medicine Open access Dec 2019 247
36 Cardiac Rehabilitation Availability and Density around the Globe Karam I. Turk-Adawi et al. · EClinicalMedicine Open access 3 Jul 2019 243
37 Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial Robert John Motzer et al. · Journal for ImmunoTherapy of Cancer Open access Jul 2020 226
38 Recommendations regarding splenectomy in hereditary hemolytic anemias Achille Iolascon et al. · Haematologica Open access 26 May 2017 225
39 The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association Elena Arbelo et al. · European Heart Journal Open access292 authors 31 Jan 2014 212
40 Macitentan in pulmonary hypertension due to left ventricular dysfunction Jean‐Luc Vachiéry, Marion Delcroix, Hikmet Al‐Hiti et al. · European Respiratory Journal Open access Feb 2018 209
41 Assistive products and the Sustainable Development Goals (SDGs) Emma Tebbutt, Rebecca Brodmann, Johan Borg et al. · Globalization and Health Open access 29 Nov 2016 205
42 MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation Jean Bousquet et al. · Allergy Open access263 authors 4 Jul 2015 205
43 Hypotension after induction of general anesthesia: occurrence, risk factors, and therapy. A prospective multicentre observational study Ondřej Jor, Jan Máca, Jiřina Koutná et al. · Journal of Anesthesia 19 Jul 2018 199
44 Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension Ján Rosa, Petr Widimský, Petr Toušek et al. · Hypertension Open access 25 Nov 2014 196
45 Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts Rastislav Horos, Hanna IJspeert, Dagmar Pospı́šilová et al. · Blood 4 Nov 2011 195
46 Violent victimization of adult patients with severe mental illness: a systematic review Klára Látalová, D. Kamarádová, Ján Pavlov Praško · Neuropsychiatric Disease and Treatment ReviewOpen access Oct 2014 195
47 A review of national guidelines for management of COPD in Europe Marc Miravitlles, Claus Franz Vogelmeier, Nicolás Roche et al. · European Respiratory Journal Open access 21 Jan 2016 193
48 Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function Jaroslav Meluzı́n, Jiřı́ Mayer, Ladislav Groch et al. · American Heart Journal 26 Oct 2006 193
49 PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups Magdalena Čížková, Aurelie Susini, Sophie Vacher et al. · Breast Cancer Research Open access 13 Feb 2012 189
50 The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy Barbora Knoppová, Colin Reily, Nicolas Maillard et al. · Frontiers in Immunology Open access 11 Apr 2016 187

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.